Results 151 to 160 of about 98,701 (282)
New biosensors and transgenic mice for multiplex cGMP imaging
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a versatile second messenger that is important for human (patho‐)physiology and pharmacotherapy. Live‐cell imaging of cGMP with biosensors allows to elucidate its spatiotemporal dynamics in real time under close‐to‐native conditions. However, to monitor two separate cGMP pools or cGMP/cAMP
Markus Wolters +6 more
wiley +1 more source
Renal Denervation for Refractory Hypertension Complicated by Acute Aortic Syndrome. [PDF]
Ye H, Qin F, Wu Z, Xu W, Zhou Q, Fu W.
europepmc +1 more source
Left brachiocephalic venous thrombus initially presenting as acute aortic syndrome. [PDF]
Yang A, Seevanayagam S.
europepmc +1 more source
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz +8 more
wiley +1 more source
Incidence, predictors and outcomes of delirium in acute aortic syndrome. [PDF]
Chen S +5 more
europepmc +1 more source
Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman +3 more
wiley +1 more source
CT Imaging Features of Acute Aortic Syndrome: A Case Series. [PDF]
Patel N +4 more
europepmc +1 more source
Coronary Calcium Association with All-Cause Mortality in Suspected Acute Aortic Syndrome. [PDF]
Perera Molligoda Arachchige AS.
europepmc +1 more source
Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes +7 more
wiley +1 more source

